Surgical treatment of benign prostatic hyperplasia: Thulium enucleation versus single-port transvesical robotic simple prostatectomy

Susan Talamini, Andrew Lai, Cassandra Palmer, Gabriel van de Walle, Marcin Zuberek, Simone Crivellaro, Susan Talamini, Andrew Lai, Cassandra Palmer, Gabriel van de Walle, Marcin Zuberek, Simone Crivellaro

Abstract

Objective: The objective of this work is to compare our outcomes using thulium laser enucleation of prostate (ThuLEP) to the single-port robot-assisted simple prostatectomy (SP RASP) in the surgical management of benign prostatic hyperplasia (BPH).

Methods: A retrospective cohort study was conducted from January 2017 through December 2021 of men who underwent SP RASP and ThuLEP performed by a single surgeon with an enucleation experience of >300 cases and extensive robotic experience. The primary outcome was changed in International Prostate Symptom Score (IPSS) postoperatively. Secondary outcomes were operative time, length of stay (LOS), change in post-void residuals (PVR), de novo stress- or urge-urinary incontinence (SUI, UUI), and rate of complications.

Results: One hundred two patients underwent surgery during the study period: 33 RASP and 69 ThuLEP. There was no difference in preoperative characteristics, including age and body mass index, between both groups. Changes in IPSS scores postoperatively were not significant between SP RASP versus ThuLEP (-17 vs. -14, p = 0.2956). SP RASP had a longer operative time (180 vs. 90 min, p < 0.0001). There was no difference in LOS (0 vs. 0 days, p = 0.2904). There was no difference in change in PVR (-96 vs. -91 mL, p = 0.8504). SP RASP patients had significantly less postoperative SUI than ThuLEP (0 vs. 13 patients, p = 0.0083), while there was no difference in UUI between both groups (4 vs. 2 patients, p = 0.0843). There was no difference in 30-day complication rate (21.2% vs. 21.7%, p = 0.9517), although there were three ThuLEP patients with Clavien-Dindo Class III or higher complication.

Conclusions: There was no difference in change in IPSS scores between the two groups. ThuLEP is associated with shorter postoperative catheter days and decreased operative times. Hospital LOS was equivalent. SP RASP demonstrates significantly improved continence rates. Though SP RASP is within the initial learning curve at our institution, early results demonstrate the role for this modality alongside ThuLEP in the treatment of large gland BPH.

Keywords: BPH; single‐port robotic prostatectomy; thulium laser enucleation.

Conflict of interest statement

Dr. Simone Crivellaro is a consultant for Intuitive Surgical, Inc. All other authors have nothing to disclose.

© 2023 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.

References

    1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–479. 10.1016/S0022-5347(17)49698-4
    1. Parsons JK, Dahm P, Köhler TS, Lerner LB, Wilt TJ. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol. 2020;204(4):799–804. 10.1097/JU.0000000000001298
    1. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al. The long‐term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–2398. 10.1056/NEJMoa030656
    1. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self‐reported diagnosed “benign prostatic hyperplasia”, and their effect on quality of life in a community‐based survey of men in the UK. BJU Int. 1999;83(4):410–415. 10.1046/j.1464-410x.1999.00966.x
    1. Welch G, Weinger K, Barry MJ. Quality‐of‐life impact of lower urinary tract symptom severity: results from the Health Professionals Follow‐up Study. Urology. 2002;59(2):245–250. 10.1016/S0090-4295(01)01506-0
    1. Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II—surgical evaluation and treatment. J Urol. 2021;206(4):818–826. 10.1097/JU.0000000000002184
    1. Herrmann TRW, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010;28(1):45–51. 10.1007/s00345-009-0503-0
    1. Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long‐term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109(3):408–411. 10.1111/j.1464-410X.2011.10359.x
    1. Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size‐independent new “gold standard”. Urology. 2005;66(5 Suppl):108–113. 10.1016/j.urology.2005.06.006
    1. Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE. Holmium laser enucleation of the prostate—outcomes independent of prostate size? J Urol. 2008. Dec;180(6):2431–2435; discussion 2435. 10.1016/j.juro.2008.08.019
    1. Bach T, Wendt‐Nordahl G, Michel MS, Herrmann TRW, Gross AJ. Feasibility and efficacy of thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol. 2009;27(4):541–545. 10.1007/s00345-008-0370-0
    1. Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2010;183(3):1105–1109. 10.1016/j.juro.2009.11.034
    1. Becker B, Herrmann TRW, Gross AJ, Netsch C. Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6‐month safety and efficacy results of a prospective randomized trial. World J Urol. 2018;36(10):1663–1671. 10.1007/s00345-018-2321-8
    1. Zhang J, Ou Z, Zhang X, He W, Wang R, Mo M, et al. Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large‐volume prostates > 80 ml: 18‐month follow‐up results. World J Urol. 2020;38(6):1555–1562. 10.1007/s00345-019-02945-x
    1. Bozzini G, Berti L, Aydoğan TB, Maltagliati M, Roche JB, Bove P, et al. A prospective multicenter randomized comparison between holmium laser enucleation of the prostate (HoLEP) and thulium laser enucleation of the prostate (ThuLEP). World J Urol. 2021;39(7):2375–2382. 10.1007/s00345-020-03468-6
    1. Kaouk J, Sawczyn G, Wilson C, Aminsharifi A, Fareed K, Garisto J, et al. Single‐port percutaneous transvesical simple prostatectomy using the SP robotic system: initial clinical experience. Urology. 2020;141:173–177. 10.1016/j.urology.2020.02.024
    1. Lai A, Dobbs RW, Talamini S, Halgrimson WR, Wilson JO, Vigneswaran HT, et al. Single port robotic radical prostatectomy: a systematic review. Transl Androl Urol. 2020;9(2):898–905. 10.21037/tau.2019.11.05
    1. Kaouk J, Garisto J, Bertolo R. Robotic urologic surgical interventions performed with the single port dedicated platform: first clinical investigation. Eur Urol. 2019;75(4):684–691. 10.1016/j.eururo.2018.11.044
    1. Talamini S, Zeinab MA, Zuberek M, Morgantini L, Beksac TA, Kaouk J, et al. Lba01‐08 prospective multi‐institutional analysis of single port simple prostatectomy outcomes. J Urol. 2021;206(Supplement 3):e1173. 10.1097/JU.0000000000002148.08
    1. Dobbs RW, Halgrimson WR, Talamini S, Vigneswaran HT, Wilson JO, Crivellaro S. Single‐port robotic surgery: the next generation of minimally invasive urology. World J Urol. 2020;38(4):897–905. 10.1007/s00345-019-02898-1
    1. LaMattina JC, Alvarez‐Casas J, Lu I, Powell JM, Sultan S, Phelan MW, et al. Robotic‐assisted single‐port donor nephrectomy using the da Vinci single‐site platform. J Surg Res. 2018;222:34–38. 10.1016/j.jss.2017.09.049
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349. 10.1016/j.jclinepi.2007.11.008
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. 10.1097/
    1. Lai A, di Meo NA, Crivellaro S. Single port robotic platform: a guide to instruments, port placement, and initial access. Urol Vid J. 2023;18:100214. 10.1016/j.urolvj.2023.100214
    1. Mourmouris P, Keskin SM, Skolarikos A, Argun OB, Karagiannis AA, Tufek I, et al. A prospective comparative analysis of robot‐assisted vs open simple prostatectomy for benign prostatic hyperplasia. BJU Int. 2019;123(2):313–317. 10.1111/bju.14531
    1. Kowalewski KF, Hartung FO, von Hardenberg J, Haney CM, Kriegmair MC, Nuhn P, et al. Robot‐assisted simple prostatectomy vs endoscopic enucleation of the prostate: a systematic review and meta‐analysis of comparative trials. J Endourol. 2022;36(8):1018–1028. 10.1089/end.2021.0788
    1. Tian Y, Zhang H, Luo G. The multi‐institutional experience in single‐port robotic transvesical simple prostatectomy for benign prostatic hyperplasia management. Letter J Urol. 2022;208(3):565–566. 10.1097/JU.0000000000002784
    1. Abou Zeinab M, Beksac AT, Corse T, Talamini S, Morgantini L, Kaviani A, et al. The multi‐institutional experience in single‐port robotic transvesical simple prostatectomy for benign prostatic hyperplasia management. J Urol. 2022;208(2):369–378. 10.1097/JU.0000000000002692
    1. Lenfant L, Kim S, Aminsharifi A, Sawczyn G, Kaouk J. Floating docking technique: a simple modification to improve the working space of the instruments during single‐port robotic surgery. World J Urol. 2021;39(4):1299–1305. 10.1007/s00345-020-03307-8
    1. Chen ML, Correa AF, Santucci RA. Urethral strictures and stenoses caused by prostate therapy. Rev Urol. 2016;18(2):90–102.
    1. Castellani D, Antonucci M, Signoretti M, Cipriani C, Vittori M, Bertolo R, et al. Urethral and bladder neck stenosis after thulium laser enucleation of the prostate: analysis of risk factors in a series of 1003 patients. Andrologia. 2022;54(9):e14523. 10.1111/and.14523
    1. Krambeck A. Does Sheath Size Matter? Wolf 24 F vs. Storz 28 F Laser Sheath Size for Holmium Laser Enucleation of the Prostate [Internet]. 2022. ; [cited 2023 Feb 20]. Report No.: NCT05308017. Available from:

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner